Contact this trialFirst, we need to learn more about you.
Medication
MK-8189 for Bipolar Disorder
Recruiting0 awardsPhase 1
Marlton, New Jersey
This trial aims to assess how safe and well-tolerated MK-8189 is in individuals with stable bipolar I disorder. The study will not involve testing specific hypotheses.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.